PD-L1 Testing and Assessment: Practical Considerations for Oncologist and Pathologist
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
PD-L1 Testing and Assessment: Practical Considerations for Oncologist and Pathologist ; day:28 ; month:11 ; year:2022
Indian journal of medical & paediatric oncology ; (28.11.2022)
- Beteiligte Personen und Organisationen
-
Pasricha, Sunil
Durga, Garima
Koyyala, Venkata Pradeep Babu
Jajodia, Ankush
Gupta, Gurudutt
Mehta, Anurag
- DOI
-
10.1055/s-0042-1748797
- URN
-
urn:nbn:de:101:1-2023011910565565231913
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pasricha, Sunil
- Durga, Garima
- Koyyala, Venkata Pradeep Babu
- Jajodia, Ankush
- Gupta, Gurudutt
- Mehta, Anurag
Ähnliche Objekte (12)
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Regulatory mechanisms of PD-1/PD-L1 in cancers
PD-1/PD-L1 binding studies using microscale thermophoresis
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Factors correlating the expression of PD-L1
Optimized PD-L1 scoring of gastric cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Regulatory mechanisms of PD-1/PD-L1 in cancers
PD-1/PD-L1 binding studies using microscale thermophoresis
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Factors correlating the expression of PD-L1
Optimized PD-L1 scoring of gastric cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Regulatory mechanisms of PD-1/PD-L1 in cancers
PD-1/PD-L1 binding studies using microscale thermophoresis
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Factors correlating the expression of PD-L1
Optimized PD-L1 scoring of gastric cancer